Search Videos and More
News
Identification and Management of Immunotherapy Toxicities
The NCCN and ASCO have developed new guidelines that describe which bodily systems can be affected by immunotherapy and how to manage side effects based on their severity.
News
Multidisciplinary Care, Specialized Clinicians Necessary for Recurrent Sarcoma Treatment
With so many different kinds of sarcoma that can be easily misdiagnosed in settings where they aren’t frequently seen, Fox Chase’s expertise in sarcoma care and its multidisciplinary team approach provide patients with more treatment options.?
News
PARP Inhibitors Now Used for First- and Second-Line Maintenance of Ovarian Cancer
The use of PARP inhibitors has changed the way ovarian cancer is treated and has improved outcomes.
News
Fox Chase Researchers Actively Recruiting for Breast Cancer Immunotherapy Trials
Recognizing the need for further evaluation of immunotherapy for breast cancer treatment, Fox Chase Cancer Center has opened two investigator-initiated trials exploring the use of immunotherapy for triple-negative and HER2-positive breast cancer.
Video
Retroperitoneoscopic Robot-Assisted Partial Nephrectomy on Morbidly Obese Patient with Tumor in the Upper Pole
Benjamin T. Ristau, MD, MHA, Randall A. Lee, MD, and Alexander Kutikov, MD, FACS, present a retroperitoneoscopic robot-assisted partial nephrectomy on a morbidly obese patient.
News
Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care
Over the last decade, dozens of predictive models have been developed to improve on the ability of stage, grade and type to predict recurrence. Unfortunately, many of the prediction models used by clinicians to guide patient care and clinical trial selection for solid tumors may not be as accurate as they are thought to be, according to a new study by researchers at Fox Chase Cancer Center.
News
De-escalating Treatment for Bladder and Prostate Cancers
Treatment approaches for bladder and prostate cancers have undergone rapid evolution in the last few years. Some patients can now safely delay or avoid surgery entirely and preserve their quality of life with positive oncological outcomes. Here are some lessons Fox Chase Cancer Center researchers are learning about these de-escalation approaches.
News
SpaceOAR Hydrogel Reduces Side Effects of Prostate Cancer Radiation Therapy
In a minimally invasive outpatient procedure, the two liquid components of SpaceOAR hydrogel are injected through the peritoneum (transperineally) into the space between the rectal wall and the prostate by a urologist. The procedure is done under anesthesia with ultrasound guidance.
News
Clinical Connections - Hypofractionation
Using hypofractionation, or hypofractionated radiation therapy, more radiation dose is delivered per treatment, so patients can complete their course of radiation therapy much faster than conventional treatment.